Pharmaceutical Analysis & Statistics in North America Countries, January 2015 (p3)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publishers

61-90 of about 6 000 reports

Purchase Reports From Reputable Market Research Publishers

Epilepsy Market in the US 2015-2019

Epilepsy Market in the US 2015-2019

  • $ 2 500
  • Industry report
  • January 2015
  • by Infiniti Research Limited

About Epilepsy Epilepsy is a spectrum of brain disorders varying from benign to severe, disabling, and life-threatening symptoms. It is caused by various factors ranging from brain malformations and tumors ...

  • Industries : Pathology
  • Countries : United States
Sickle-cell Anemia Therapeutics Market in the US 2015-2019

Sickle-cell Anemia Therapeutics Market in the US 2015-2019

  • $ 2 500
  • Industry report
  • January 2015
  • by Infiniti Research Limited

About Sickle-cell Anemia Sickle-cell anemia is a disease characterized by the presence of sickle-shaped erythrocytes. While normal erythrocytes have a life span of 120 days, sickle-shaped erythrocytes ...

  • Industries : Therapy
  • Countries : United States
Pleural Effusion Global Clinical Trials Review, H2, 2014

Pleural Effusion Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • December 2014
  • by Global Data

Pleural Effusion Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Pleural Effusion Global Clinical Trials Review, H2, 2014" provides data on the Pleural Effusion clinical ...

  • Industries : Drug Discovery and Development
  • Countries : World, United States
Fanconi Anemia Global Clinical Trials Review, H2, 2014

Fanconi Anemia Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • December 2014
  • by Global Data

Fanconi Anemia Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Fanconi Anemia Global Clinical Trials Review, H2, 2014" provides data on the Fanconi Anemia clinical ...

  • Industries : Drug Discovery and Development
  • Countries : World, United States
Trichomonas Vaginitis Global Clinical Trials Review, H2, 2014

Trichomonas Vaginitis Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • December 2014
  • by Global Data

Trichomonas Vaginitis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Trichomonas Vaginitis Global Clinical Trials Review, H2, 2014" provides data on the Trichomonas ...

  • Industries : Drug Discovery and Development
  • Countries : World, United States
Onchocerciasis (River Blindness) Global Clinical Trials Review, H2, 2014

Onchocerciasis (River Blindness) Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • December 2014
  • by Global Data

Onchocerciasis (River Blindness) Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Onchocerciasis (River Blindness) Global Clinical Trials Review, H2, 2014" provides ...

  • Industries : Pathology
  • Countries : World, United States
Atelectasis Global Clinical Trials Review, H2, 2014

Atelectasis Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • December 2014
  • by Global Data

Atelectasis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Atelectasis Global Clinical Trials Review, H2, 2014" provides data on the Atelectasis clinical trial scenario. ...

  • Industries : Drug Discovery and Development
  • Countries : World, United States
Chronic Bronchitis Global Clinical Trials Review, H2, 2014

Chronic Bronchitis Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • December 2014
  • by Global Data

Chronic Bronchitis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Chronic Bronchitis Global Clinical Trials Review, H2, 2014" provides data on the Chronic Bronchitis ...

  • Industries : Drug Discovery and Development
  • Countries : World, United States
Allergic Asthma Global Clinical Trials Review, H2, 2014

Allergic Asthma Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • December 2014
  • by Global Data

Allergic Asthma Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Allergic Asthma Global Clinical Trials Review, H2, 2014" provides data on the Allergic Asthma clinical ...

  • Industries : Drug Discovery and Development
  • Countries : World, United States
HIV-1 Infection Global Clinical Trials Review, H2, 2014

HIV-1 Infection Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • November 2014
  • by Global Data

HIV-1 Infection Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “HIV-1 Infection Global Clinical Trials Review, H2, 2014" provides data on the HIV-1 Infection clinical ...

  • Industries : Drug Discovery and Development
  • Countries : World, United States
Chlamydia Infections Global Clinical Trials Review, H2, 2014

Chlamydia Infections Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • November 2014
  • by Global Data

Chlamydia Infections Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Chlamydia Infections Global Clinical Trials Review, H2, 2014" provides data on the Chlamydia ...

  • Industries : Drug Discovery and Development
  • Countries : World, United States
Cystic Fibrosis Global Clinical Trials Review, H2, 2014

Cystic Fibrosis Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • November 2014
  • by Global Data

Cystic Fibrosis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Cystic Fibrosis Global Clinical Trials Review, H2, 2014" provides data on the Cystic Fibrosis clinical ...

  • Industries : Pathology
  • Countries : World, United States
Abscess-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Abscess-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Abscess-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the ...

  • Industries : Drug and Medication
  • Countries : United States
Absence Seizure-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Absence Seizure-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Absence Seizure-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across ...

  • Industries : Drug and Medication
  • Countries : United States
Acid Indigestion / Heartburn/ Pyrosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Acid Indigestion / Heartburn/ Pyrosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Acid Indigestion / Heartburn/ Pyrosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs ...

  • Industries : Drug and Medication
  • Countries : United States
Acne Vulgaris-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Acne Vulgaris-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Acne Vulgaris-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across ...

  • Industries : Pathology
  • Countries : United States
Acquired (Autoimmune) Hemolytic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Acquired (Autoimmune) Hemolytic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Acquired (Autoimmune) Hemolytic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs ...

  • Industries : Pathology
  • Countries : United States
Actinic (Solar) Keratosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Actinic (Solar) Keratosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Actinic (Solar) Keratosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed ...

  • Industries : Drug and Medication
  • Countries : United States
Acute Bacterial Sinusitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Acute Bacterial Sinusitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Acute Bacterial Sinusitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed ...

  • Industries : Drug and Medication
  • Countries : United States
Acute Bronchitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Acute Bronchitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Acute Bronchitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across ...

  • Industries : Pathology
  • Countries : United States
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about ...

  • Industries : Pathology
  • Countries : United States
Acute Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Acute Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Acute Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across ...

  • Industries : Therapy
  • Countries : United States
Acute Rheumatic Carditis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Acute Rheumatic Carditis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Acute Rheumatic Carditis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed ...

  • Industries : Drug and Medication
  • Countries : United States
Alcohol Addiction-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Alcohol Addiction-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Alcohol Addiction-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs ...

  • Industries : Drug and Medication
  • Countries : United States
Allergic Conjunctivitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Allergic Conjunctivitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Allergic Conjunctivitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed ...

  • Industries : Therapy
  • Countries : United States
Alzheimer's Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Alzheimer's Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Alzheimer's Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs ...

  • Industries : Pathology
  • Countries : United States
Amenorrhea-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Amenorrhea-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Amenorrhea-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across ...

  • Industries : Drug and Medication
  • Countries : United States
Amoebiasis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Amoebiasis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Amoebiasis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across ...

  • Industries : Drug and Medication
  • Countries : United States
Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the ...

  • Industries : Drug and Medication
  • Countries : United States
Angina (Angina Pectoris)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Angina (Angina Pectoris)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Angina (Angina Pectoris)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed ...

  • Industries : Pathology
  • Countries : United States
About 22 000 reports

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US - Forecast

  • February 2015
    9 pages
  • Pathology  

    Mental Health  

    Real Estate  

  • United States  

View report >

About 100 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Novartis Inc.

Switzerland

Abbott Laboratories

United States

Pfizer Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.